Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.94 |
---|---|
High | 23.94 |
Low | 23.94 |
Bid | 24.18 |
Offer | 24.85 |
Previous close | 23.94 |
Average volume | -- |
---|---|
Shares outstanding | 62.76m |
Free float | 61.11m |
P/E (TTM) | -- |
Market cap | 273.02m USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Mar 08 2021.
More ▼
- MacroGenics to Participate in Upcoming Investor Conferences
- MacroGenics Announces Leadership Transition
- MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
- MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
- MacroGenics Provides Vobramitamab Duocarmazine Update
- MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
- MacroGenics to Participate in Upcoming Investor Conference
- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
- MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
More ▼